Pfizer Inc recalls RELPAX — RELPAX® (eletriptan hydrobromide) 40 mg tablets
- Recall date
- August 15, 2019
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Brand / firm
- Pfizer Inc, RELPAX
Why it was recalled
Microbiological Contamination — Unapproved Ingredient
What was recalled
RELPAX® (eletriptan hydrobromide) 40 mg tablets
Read the official recall notice →
Get recall alerts
Free email alert whenever Pfizer Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Pfizer Inc, RELPAX